Finance

Lists
603520:SHA
Zhejiang Starry Pharmaceutical Co Ltd
CN¥7.94
-1.00%
(-0.080) 1D
Oct 30, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603520...
Open
CN¥8.00
High
CN¥8.16
Low
CN¥7.88
Mkt. cap
3.48B
Avg. vol.
6.48M
Volume
6.55M
Dividend
3.78%
Quarterly dividend
CN¥0.08
Ex-dividend date
Sep 11, 2026
P/E ratio
135.19
52-wk high
CN¥14.37
52-wk low
CN¥7.64
EPS
CN¥0.06
Shares outstanding
120.00M
No. of employees
2K
Open
CN¥8.00
High
CN¥8.16
Low
CN¥7.88
Mkt. cap
3.48B
Avg. vol.
6.48M
Volume
6.55M
Dividend
3.78%
Quarterly dividend
CN¥0.08
Ex-dividend date
Sep 11, 2026
P/E ratio
135.19
52-wk high
CN¥14.37
52-wk low
CN¥7.64
EPS
CN¥0.06
Shares outstanding
120.00M
No. of employees
2K
News stories
From web sources and news partners
About Zhejiang Starry Pharmaceutical Co Ltd
CEO-
Employees1.9K
FoundedSep 15, 1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
600.76M
711.27M
703.00M
594.01M
Cost of goods sold
530.64M
552.98M
594.09M
450.31M
Cost of revenue
530.64M
552.98M
594.09M
450.31M
Research and development expenses
37.20M
28.28M
30.92M
38.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.26M
65.75M
65.82M
57.43M
Operating expense
100.75M
96.26M
94.33M
90.80M
Total operating expenses
631.39M
649.25M
688.43M
541.11M
Operating income
-30.63M
62.02M
14.57M
52.90M
Other non operating income
-17.11M
-10.36M
5.04M
-60.56M
EBT including unusual items
-30.84M
27.63M
26.02M
8.02M
EBT excluding unusual items
-46.43M
33.32M
14.08M
32.97M
Income tax expense
-11.95M
6.82M
6.91M
2.78M
Effective tax rate
38.76%
24.67%
26.56%
34.63%
Other operating expenses
8.64M
-3.30M
1.55M
-3.25M
Net income
-18.60M
20.95M
18.98M
5.25M
Net profit margin
-3.10%
2.95%
2.70%
0.88%
Earnings per share
-
-
-
-
Interest and investment income
360.05K
373.10K
23.18M
37.83M
Interest expense
-19.19M
-18.71M
-19.11M
-6.80M
Net interest expenses
-18.83M
-18.34M
4.06M
31.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
28.95M
121.60M
74.50M
112.48M
Gain or loss from assets sale
-447.30K
-
29.94K
-29.94K
Upcoming events
AI content may include mistakes. Learn more
Google apps